The deadline for Scientific Poster Submissions has now passed. Thank you for all submissions.
The posters will be displayed in the congress exhibition hall and will stay up throughout the congress Nov 28 - 30. If you are listed below please arrive on the morning of the Nov 28 to put them up on the boards within the Poster Zone.
We are also promoting all attendees to
visit the Poster Zone at:
12:40 on Nov 28, 13:30 on Nov 29, and 13:00 on Nov 30.
Poster presenters should be stationed next to their poster at these times.
Organization or Academic Institution
Jimena Werner-Sunderland, MD, MPH, Daniela Bautista-Reyes, BSc, Alondra Coral Aragón-Gama, BSc, MPH. José Roberto Cabral Duran, BSc, MSc Karla Daniela Contreras-Medina, BSc, Manuel Urbina-Fuentes, MD, MSc et Elysse Bautista-Gonzalez, MD, MSc, PhD
Latinxs Against AMR
Health-care & vaccines policies during the COVID-19 pandemic in Mexico: a continuous case of heterogeneous, reactive, and unequal response
Revolutionizing Vaccine Science: WestGene Pharma's Innovative mRNA Platforms
V-212, a novel peptide-based serotype-independent vaccine candidate against Streptococcus pneumoniae
SolaVAX: A Novel Photochemical Inactivation Method for the Rapid Production of Whole-Pathogen Vaccines
Development of a Shigella Vaccine Using Cell-Free to Express Invasion Plasmid Antigen B (IpaB) and Its Cognate Chaperone IpgC
La Jolla Institute for Immunology
Defining the features facilitating accurate prediction of antibodies binding to the same epitope
Decameric ACE2 as pan-COVID therapeutic
Biomarker strategy and approaches for evaluating humoral immune responses to the seasonal influenza mRNA vaccine in humans
Production of SARS-CoV-2 Spike RBD using the Baculovirus Expression System
Single-Step Column Purification for H1N1 Virus Using an Anion Exchange Chromatography Resin
Treatment of immune "cold" tumors with engineered extracellular vesicle-based therapeutic cancer vaccine
Precision Insights into the Stability of Vaccine Formulations via Optical Imaging
University of Southern California
New and more effective prodrugs against adenovirus, other DNA viruses and coronavirus: development of a versatile, targetable and highly tunable promoiety platform for nucleoside phosphonates and phosphates.
A novel HIV nanoparticle vaccine displaying glycan-trimmed Env trimers elicits tier 2 neutralizing antibody responses in mice, rats, and rhesus macaques
MULTI-seq: lipid-conjugated DNA barcodes for multiplexed single-cell sequencing
mRNA and DNA vaccines formulated onto gold microparticles are stable at room-temperature for up to 6 months post-formulation.
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116, a Pneumococcal Conjugate Vaccine Designed for Adults (STRIDE-3)
A CPAF-adjuvant conjugate vaccine demonstrates robust Th1/17 responses and significantly reduces Chlamydia burden in female mice
Keegan Braz Gomes
Flu Fighters: A single-component self-assembling protein nanoparticle presenting tandem M2e as a universal influenza A vaccine
University of Arizona
Identification of small molecule inhibitors against the nsP2 protease (nsP2pro) of Chikungunya virus
Novel adjuvant discovery using machine learning analyses of human PBMC treated with a large, bioactive compound library
Queen's University Belfast
Killing two birds with one stone: Novel T-cell based cross-protective vaccines
AAV8 Scalable Purification Using Mixed-Mode Chromatography